Showing results (231-240 of 337) with videos related to

Sort By:
Pageof 34
Diabetes, Obesity & Metabolism|December 23, 2017
Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trialSuk Chon, Sang Youl Rhee, Kyu Jeung Ahn, et al.
JTO Clinical and Research Reports|September 22, 2025
First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With RET Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup AnalysisKoichi Goto, Herbert H Loong, Caicun Zhou, et al.
Diabetes & Metabolism Journal|May 21, 2020
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes AssociationByung Wan Lee, Yong Ho Lee, Cheol Young Park, et al.
Leukemia & Lymphoma|June 27, 2009
Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in KoreaMyung Hee Chang, Seok Jin Kim, Kihyun Kim, et al.
The Oncologist|December 26, 2022
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint InhibitorsFabrice Barlesi, Nicolas Isambert, Enriqueta Felip, et al.
Cancer Letters|August 2, 2003
Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancerHyun Kyung Kim, Kyung Soon Song, Hyun Ok Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2013
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancerDae Ho Lee, Jung Shin Lee, Sang-We Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitusSang Ah Lee, Young Ree Kim, Eun Jin Yang, et al.
Investigational New Drugs|June 24, 2009
Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaByung Woog Kang, Won Seog Kim, Chul Kim, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 15, 2019
Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosisKiyoung Lee, Ie Byung Park, Seung Hee Yu, et al.
Pageof 34